Pfizer-Biotech COVID-19 Vaccine Approved by FDA

Posted on August 25th, 2021
Vaccine News

On August 23, 2021, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (pronounced koe-mir’-na-tee) for the prevention of COVID-19 disease in individuals 16 years of age and older.

The vaccine also continues to be available under emergency use authorization (EUA), including for individuals 12 through 15 years of age and for the administration of a third dose in certain immunocompromised individuals.

Read the FDA News Release at www.fda.gov/news-events/press-announcements/fda-approves-first-covid-19-vaccine.

If you need your first or second dose of the COVID-19 vaccine, find a vaccine location near you and get vaccinated! The Health Department continues to offer COVID-19 vaccine free of charge. No appointment is necessary – just walk in.

 

Pfizer-Biotech COVID-19 Vaccine received FDA approval for use in individuals 16 and over.